Litcius/Paper detail

Small-Molecule Inhibitors of the m7G-RNA Writer METTL1

Francesco Nai, María Paula Flores-Espinoza, Annalisa Invernizzi, Pablo Andrés Vargas-Rosales, Olga Bobiļeva, Marcin Herok, Amedeo Caflisch

2023ACS Bio & Med Chem Au29 citationsDOIOpen Access PDF

Abstract

High Resolution Image Download MS PowerPoint Slide We discovered the first inhibitors of the m7G-RNA writer METTL1 by high-throughput docking and an enzymatic assay based on luminescence. Eleven compounds, which belong to three different chemotypes, show inhibitory activity in the range 40–300 μM. Two adenine derivatives identified by docking have very favorable ligand efficiency of 0.34 and 0.31 kcal/mol per non-hydrogen atom, respectively. Molecular dynamics simulations provide evidence that the inhibitors compete with the binding of the cosubstrate S -adenosyl methionine to METTL1. We also present a soakable crystal form that was used to determine the structure of the complex of METTL1 with sinefungin at a resolution of 1.85 Å.

Topics & Concepts

RNAMoleculeChemistryBiochemistryGeneOrganic chemistryRNA modifications and cancerCancer-related molecular mechanisms researchRNA Research and Splicing
Small-Molecule Inhibitors of the m7G-RNA Writer METTL1 | Litcius